Coronary artery disease (CAD) and its complications are the leading cause of death
worldwide. Inflammatory activation and dysfunction of the endothelium are key events in the …

Metabolic syndrome (MS) is a chronic non‐infective syndrome characterised clinically by a
set of vascular risk factors that include insulin resistance, hypertension, abdominal obesity …

Cardiovascular disease (CVD) is the leading cause of death worldwide, and extensive
research has been performed to understand this disease better, using various experimental …

Atherosclerosis, the chronic accumulation of cholesterol-rich plaque within arteries, is
associated with a broad spectrum of cardiovascular diseases including myocardial …

Metformin is one of the most widely prescribed hypoglycemic drugs and has the potential to
treat many diseases. More and more evidence shows that metformin can regulate the …

Atherosclerosis remains the underlying process responsible for cardiovascular diseases
and the high mortality rates associated. This chronic inflammatory disease progresses with …

In addition to their cholesterol-lowering effects, statins are associated with pleiotropic effects
including improvements in heart failure (HF), reduced blood pressure, prevention of the …

Atherosclerosis is a chronic inflammatory, metabolic, and epigenetic disease, which leads to
the life‐threatening coronary artery disease. Emerging studies from bench to bedside have …

Atherosclerosis is a chronic inflammatory disorder characterized by the gradual buildup of
plaques within the vessel wall of middle-sized and large arteries. The occurrence and …

Curcumin, a natural polyphenolic compound present in Curcuma longa L. rhizomes, shows
potent antioxidant, anti-inflammatory, anti-cancer, and anti-atherosclerotic properties …